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The optimization of nanoparticles (NPs) for drug delivery, in particular to target the blood brain 
barrier (BBB), imposes to verify their hemocompatibility both for toxicology and targeting efficiency 
perspectives. The large surface area of the NPs that can be exposed to the biological environment 
promotes their interaction with various biochemicals, in particular proteins which, following 
adsorption, can elicit the activation of biological cascades responsible either for NPs clearance or/and 
harmful body reactions (inflammatory / coagulation).  
In the framework of the European Integrated Project : “Nanobiopharmaceutics”, we had the 
opportunity to compare in vitro the hemoreactivity of about 145 different NP samples differing in core 
and surface chemistry and classified according to their expected difference in hydrophobicity based on 
the nature of their core materials. According to this classification, poly(lactide-co-glycolide) (PLGA) 
nanoparticles, polyglycidol-polyethyethylene oxide nanoparticles, polyglycidol thyolated or 
polyacrylamide nanogels, and polyelectrolyte complexes either based on polyamidoamine or 
poly(N,N-dimethylamino-2-ethylmethacrylate) have been evaluated within a concentration range of 
0.3 to 1000 µg/mL. The in vitro tests have been performed for screening purposes adopting normal 
human bloods and according to Iso 10993. 
The results of this extensive study clearly highlighted that most of the polymeric nanoparticles 
evaluated give rise to some alterations of the blood components. In particular the platelets, the intrinsic 
pathway of coagulation and the complement activation were found to be the most reactive biological 
parameters in the presence of these nanostuctures.  
Although not strictly related to their surface chemistry, the classification of the NPs allowed us to 
derive some clear correlations between the nanomaterial properties and their hemoreactivity.  
Within the class of polyelectrolyte complexes, the modification of the surface chemistry was found to 
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